These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34179694)

  • 1. SARS-CoV-2-Induced Multisystem Inflammatory Syndrome in a Young Adult: Case Report.
    Bulut H; Herbers AHE; Hageman IMG; Netten PM; de Jonge HJM; Joustra R; van de Veerdonk FL; de Jager CPC
    SN Compr Clin Med; 2021; 3(8):1773-1779. PubMed ID: 34179694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Spectrum of Manifestations of Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV2) Infection in Children: What We Can Learn From Multisystem Inflammatory Syndrome in Children (MIS-C).
    Panaro S; Cattalini M
    Front Med (Lausanne); 2021; 8():747190. PubMed ID: 34778310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multisystem Inflammatory Syndrome in a Young Adult (MIC-A) Following SARS-CoV-2 Infection.
    Bajoriunaite A; Zaveckiene J; Usaite A; Dobiliene O; Tamosuitis T
    Medicina (Kaunas); 2022 Oct; 58(11):. PubMed ID: 36363472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics of children with MIS-C fulfilling classification criteria for macrophage activation syndrome.
    Buda P; Strauss E; Januszkiewicz-Lewandowska D; Czerwinska E; Ludwikowska K; Szenborn L; Gowin E; Okarska-Napierała M; Kuchar E; Ksia Zyk J
    Front Pediatr; 2022; 10():981711. PubMed ID: 36186637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case Report: Case Series of Children With Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Switzerland.
    Fouriki A; Fougère Y; De Camaret C; Blanchard Rohner G; Grazioli S; Wagner N; Relly C; Pachlopnik Schmid J; Trück J; Kottanatu L; Perez E; Perez MH; Schaffner D; Asner SA; Hofer M
    Front Pediatr; 2020; 8():594127. PubMed ID: 33469522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory biomarkers in COVID-19-associated multisystem inflammatory syndrome in children, Kawasaki disease, and macrophage activation syndrome: a cohort study.
    Rodriguez-Smith JJ; Verweyen EL; Clay GM; Esteban YM; de Loizaga SR; Baker EJ; Do T; Dhakal S; Lang SM; Grom AA; Grier D; Schulert GS
    Lancet Rheumatol; 2021 Aug; 3(8):e574-e584. PubMed ID: 34124694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-Linked Lymphoproliferative Disease Mimicking Multisystem Inflammatory Syndrome in Children-A Case Report.
    Prader S; Ritz N; Baleydier F; Andre MC; Stähli N; Schmid K; Schmid H; Woerner A; Diesch T; Meyer Sauteur PM; Trück J; Gebistorf F; Opitz L; Killian MP; Marchetti T; Vavassori S; Blanchard-Rohner G; Mc Lin V; Grazioli S; Pachlopnik Schmid J
    Front Pediatr; 2021; 9():691024. PubMed ID: 34414143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinguishing immune activation and inflammatory signatures of multisystem inflammatory syndrome in children (MIS-C) versus hemophagocytic lymphohistiocytosis (HLH).
    Kumar D; Rostad CA; Jaggi P; Villacis Nunez DS; Prince C; Lu A; Hussaini L; Nguyen TH; Malik S; Ponder LA; Shenoy SPV; Anderson EJ; Briones M; Sanz I; Prahalad S; Chandrakasan S
    J Allergy Clin Immunol; 2022 May; 149(5):1592-1606.e16. PubMed ID: 35304157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children.
    Lee PY; Day-Lewis M; Henderson LA; Friedman KG; Lo J; Roberts JE; Lo MS; Platt CD; Chou J; Hoyt KJ; Baker AL; Banzon TM; Chang MH; Cohen E; de Ferranti SD; Dionne A; Habiballah S; Halyabar O; Hausmann JS; Hazen MM; Janssen E; Meidan E; Nelson RW; Nguyen AA; Sundel RP; Dedeoglu F; Nigrovic PA; Newburger JW; Son MBF
    J Clin Invest; 2020 Nov; 130(11):5942-5950. PubMed ID: 32701511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain.
    García-Salido A; de Carlos Vicente JC; Belda Hofheinz S; Balcells Ramírez J; Slöcker Barrio M; Leóz Gordillo I; Hernández Yuste A; Guitart Pardellans C; Cuervas-Mons Tejedor M; Huidobro Labarga B; Vázquez Martínez JL; Gutiérrez Jimeno M; Oulego-Erróz I; Trastoy Quintela J; Medina Monzón C; Medina Ramos L; Holanda Peña MS; Gil-Antón J; Sorribes Ortí C; Flores González JC; Hernández Palomo RM; Sánchez Ganfornina I; Fernández Romero E; García-Besteiro M; López-Herce Cid J; González Cortés R;
    Crit Care; 2020 Nov; 24(1):666. PubMed ID: 33243303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management.
    Nakra NA; Blumberg DA; Herrera-Guerra A; Lakshminrusimha S
    Children (Basel); 2020 Jul; 7(7):. PubMed ID: 32630212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case Report: Secondary Hemophagocytic Lymphohistiocytosis (sHLH) and
    Gautam S; Sharma G; Singla S; Garg S
    Front Med (Lausanne); 2022; 9():835421. PubMed ID: 35783658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical aspects and presumed etiology of multisystem inflammatory syndrome in children (MIS-C): A review.
    Kundu A; Maji S; Kumar S; Bhattacharya S; Chakraborty P; Sarkar J
    Clin Epidemiol Glob Health; 2022; 14():100966. PubMed ID: 35132389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of COVID-19-associated multisystem inflammatory syndrome in children (MIS-C) and Kawasaki disease shock syndrome: case reports and literature review.
    Lee S; Kim D; Kim BJ; Rhim JW; Lee SY; Jeong DC
    J Rheum Dis; 2023 Oct; 30(4):272-277. PubMed ID: 37736588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case report: Multisystem inflammatory syndrome in children associated with COVID-19, macrophage activation syndrome, and incomplete Kawasaki disease.
    Martínez-García JJ; López-Acosta JR; Arce-Cabrera D; León-Sicairos N; Hernández-Parra AC; Cuen-Diaz HM; Zatarain-Lopez R; Canizalez-Roman A
    Front Pediatr; 2023; 11():1167828. PubMed ID: 37138560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Arab Adolescent with Multisystem Inflammatory Syndrome Associated with COVID-19: A Report from Syria.
    Zaino J; Bakri A; Al Sayed Ahmad A; Hadba G
    Avicenna J Med; 2021 Oct; 11(4):221-224. PubMed ID: 34881206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythema and Induration of Bacillus Calmette-Guérin Scar Associated With Multisystem Inflammatory Syndrome in Children in Japan: A Case Report.
    Tsuboya N; Makino H; Mitani Y; Ito M; Ohya K; Morimoto M; Hanaki R; Yodoya N; Ohashi H; Sawada H; Sugiyama K; Hirayama M
    Front Pediatr; 2022; 10():849473. PubMed ID: 35359902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multisystem Inflammatory Syndrome in an Adult (MIS-A) Successfully Treated with Anakinra and Glucocorticoids.
    Cattaneo P; Volpe A; Cardellino CS; Riccardi N; Bertoli G; Ursini T; Ustalli A; Lodi G; Daroui I; Angheben A
    Microorganisms; 2021 Jun; 9(7):. PubMed ID: 34203277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Understanding of Multisystem Inflammatory Syndrome (MIS-C) Following COVID-19 and Its Distinction from Kawasaki Disease.
    Bukulmez H
    Curr Rheumatol Rep; 2021 Jul; 23(8):58. PubMed ID: 34216296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 associated Multisystem Inflammatory Syndrome in Children (MIS-C) guidelines; a Western New York approach.
    Hennon TR; Penque MD; Abdul-Aziz R; Alibrahim OS; McGreevy MB; Prout AJ; Schaefer BA; Ambrusko SJ; Pastore JV; Turkovich SJ; Gomez-Duarte OG; Hicar MD
    Prog Pediatr Cardiol; 2020 May; ():101232. PubMed ID: 32837142
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.